LncRNA ZNF649-AS1 promotes trastuzumab resistance and TAM-dependent PD-L1 expression in breast cancer by regulating EXOC7 alternative splicing
Article in Archives of Biochemistry and Biophysics (August 2024)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
The splicing factor proline and glutamine rich promotes the growth of osteosarcoma via the c-Myc signaling pathway.
Article in American Journal of Cancer Research (June 2023)
The interplay between non-coding RNAs and alternative splicing: from regulatory mechanism to therapeutic implications in cancer
Article in Theranostics (April 2023)